Medifast, Inc. Announces Fourth Quarter and Full Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Medifast (MED) Tops Q4 EPS by 59c, Revenues Beat; Offers Q1 & FY20 EPS/Revenue Guidance Below Consensus
February 26, 2020 4:46 PM ESTMedifast (NYSE: MED) reported Q4 EPS of $1.66, $0.59 better than the analyst estimate of $1.07. Revenue for the quarter came in at $170.6 million versus the consensus estimate of $161.69 million.
Fourth Quarter 2019 Highlights Compared to Prior-Year Period
Revenue up 17.0% to $170.6 million32.0% growth in active earning OPTAVIA Coaches to 31,800Net income increased 27.0% to $19.9 millionEarnings per diluted share ("EPS") of $1.66, an increase of 27.7%Declared a quarterly cash dividend of $13.4 million, or $1.13 per share paid on February 6, 2020, an increase of over 50%... More